Free tool
FAERS Monitor: Multrys
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209376 or its brand name (Multrys, Cupric Sulfate, Manganese Sulfate, Selenious Acid, Zinc Sulfate). Reports on generic versions are filed under their own applications.
Reports
14
Serious
10
71% of reports
Hospitalization
9
Death reported
1
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pyrexia4
- product label confusion3
- anaemia2
- diarrhoea2
- fall2
- hospitalisation2
- infection2
- muscular weakness2
- pain2
- physical product label issue2
- product dose omission issue2
- vomiting2
- weight decreased2
- abdominal discomfort1
- abdominal pain1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 7 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,145 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| physical product label issue | 2 | 2531.8 | 700.8 | 2,841 |
| product label confusionSignal | 3 | 773.7 | 283.7 | 1,607 |
| muscular weakness | 2 | 26.4 | 7.3 | 27 |
| infection | 2 | 20.8 | 5.8 | 21 |
| hospitalisation | 2 | 19.6 | 5.4 | 19 |
| pyrexiaSignal | 4 | 17.4 | 7.6 | 47 |
| anaemia | 2 | 15.8 | 4.4 | 15 |
| weight decreased | 2 | 10.8 | 3.0 | 9 |
| product dose omission issue | 2 | 10.2 | 2.8 | 9 |
| fall | 2 | 9.0 | 2.5 | 7 |
| abdominal discomfort | 1 | 9.0 | 1.4 | 1 |
| abdominal pain | 1 | 6.5 | 1.0 | 1 |
| vomiting | 2 | 6.4 | 1.8 | 5 |
| pain | 2 | 4.9 | 1.4 | 3 |
| diarrhoea | 2 | 4.7 | 1.3 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.